Retrieved from Medications containing semaglutide marketed for type 2 diabetes or weight loss
The full texts of the remaining papers were separately reviewed, and disagreements were resolved by a third, blinded reviewer, who independently made a final decision on disputed studies, ensuring an unbiased resolution process
Explore More Health From the economic impacts of GLP-1s to the ways AI is shaping mental health care to breakthroughs in gene editing, this year's Aspen Ideas: Health sessions tackled today's big
After implementing some of these strategieseating smaller, more frequent meals, avoiding high-fat foods, and using a short course of anti-nausea medication during dose increasesthey found their nausea became much more manageable
Impact of Glucagon-Like Peptide-1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population-Based Longitudinal Cohort Study